Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review.
Tesemma SileshiGosaye Mekonnen TeferaEyasu Mekonnen EshetuEleni AklilluPublished in: Pharmacogenomics and personalized medicine (2022)
The pharmacokinetics of rifamycins is influenced by genetic variation of drug-metabolizing enzymes and transporters. Controlled clinical studies are, however, required to establish these relationships.